Concurrent to the call to action contained on numerous Presidential Executive Orders and Section 3202 of the Coronavirus Aid, Relief, and Economic Security Act, Hercules Pharmaceuticals has conducted an advanced national security analysis and geopolitical analysis of the U.S. pharmaceutical supply chain and share this analysis with relevant touchpoints in U.S. Government.
We're proud of our Hofstra Alumni Brianni Lyons, who brings passion and talent to the Hercules team. In the article, Brianni, recalls her student years and the decisions that benefited her professional career, specifically the wide variety of experience during each semester, "The variety of my ensuing legal experience was a great competitive advantage to me for a career as a corporate lawyer, and it helped me to clearly identify my professional preferences and legal interests."
Read the Law News article here.
Hercules Pharmaceuticals announces that in March of 2020, its President Timothy M. Ward, Esq. has been appointed to the Board of Directors for the Partnership for DSCSA Governance (PDG). The PDG is an independent, balanced, sector-neutral, not-for-profit governance body that supports the secure, electronic, interoperable tracing and verification of prescription drugs in the U.S. Pharmaceutical Supply Chain as required by the Drug Supply Chain Security Act.
Hercules has invested in a multi-phase expansion for our cold chain capacity to meet the industry's demands. Hercules is an ISTA (International Safe Transit Association) member and an NABP accredited National Pharmaceutical Cold Chain distributor.
The topic for this timely event was 'COVID-19 - Diagnosing the new health and legal outlook.' Speakers focussed mainly on how COVID-19 has changed panelists' legal practices or careers. Hercules President Timothy M. Ward, Esq., touched upon the issues of COVID-19 exposing critical weaknesses in the U.S. healthcare supply chain and "deep systemic risk..." both domestically and with our trade partners.
Hercules President Timothy M. Ward, Esq., was invited to contribute to the NASP Conference in Washington, DC, on September 10th. Mr. Ward, who also serves on the Board of Directors of the National Association of Specialty Pharmacy, discussed 'Fulfillment: Aligning Processes to Best Standards of Care.'
Topics included: best practices on complying with the Drug Supply Chain Security Act, updates to prescription handling and cold chain management standards, and advancements in packaging, returns handling, and other areas of the fulfillment process. Hercules is a firm supporter of NASP and will continue to align our values with this reputable organization.
Timothy M. Ward, Esq. presented on biosimilars at the 2019 New York State Bar Association Annual Meeting FDA Law Section held on Thursday, January 17, 2019, at the New York Hilton Midtown. Timothy is President of Hercules Pharmaceuticals, a VAWD accredited national specialty distributor, and serves on the National Association of Specialty Pharmacy (NASP).
Before Hercules Pharmaceuticals, Tim was Chief Legal Officer of a multinational corporation, conducting business in highly regulated markets and directing the group's government affairs efforts. Tim has served on boards for numerous Washington DC trade and industry groups and participated in advisory committee capacity regarding economic sanctions, trade compliance, and foreign policy.
Hercules Pharmaceuticals is a wholesale distributor actively engaged in the political fight to return market-based economics to the drug supply chain and fight for transparency and fairness from the payor side. For more information about this event, visit www.nysba.org/AM2019